Ligand to Report Third Quarter Results on November 9th
Go back to Ligand to Report Third Quarter Results on November 9th| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 296.77 +2.17 (0.74%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $294.60 | 52 Week High | $139.79 | |||
| Open | $292.47 | 52 Week Low | $82.07 | |||
| Day High | $298.29 | P/E | 690.16 | |||
| Day Low | $292.47 | EPS | $0.43 | |||
| Volume | 48,772 | |||||

